Pharmagnetic is a consortium of pharmaceutical and technology-orientated companies, with university and non- univerisity research support . Every of the network partners has deep expertise in a specific field of drug development. Therefore it possible to serve a broad range of questions regarding advanced early drug development. The most important link is the active drug release system MAARS (magnetic active agent release system) that allows to deliver drugs precisely into the gastrointestinal tract of animals and volunteers.

Pharmagnetic is organized by Matesy GmbH and the independent R&D-foundation INNOVENT.

For detailed information, please contact us!

The Pharmagnetic innovationfor pharmaceutical development and medication:
The targeted drug release into the gastrointestinal tract: safe and effective!

Join our network!